Strategic Acquisition Arterys has a history of acquisitions and is now under Tempus AI, indicating potential cross-sell opportunities to Tempus customers and integration synergies with Tempus imaging analytics platforms.

FDA Cleared Expertise With multiple FDA clearances and a cloud-based AI platform focused on radiology, there is strong credibility for selling to hospitals seeking compliant, scalable AI imaging solutions and workflow integrations.

Global Reach Active in 118 countries and collaborations across US and EU markets present opportunities to expand into new geographies and partner channels, especially with distributors like Therapixel in breast imaging.

Cardio and Imaging Focus A robust Cardio AI suite and various imaging modules position Arterys to upsell to radiology departments needing comprehensive, workflow-integrated AI across multiple modalities.

Partnership Ecosystem Strategic partnerships and distribution agreements, including Therappixel and cross-acquisitions, create avenues for co-sales, bundled offerings, and faster deployment in larger health systems.